Tech Company Financing Transactions
TyRx Pharma Funding Round
HLM Venture Partners, Clarus and Comerica Bank participated in a $20 million funding round for TyRx Pharma. The funding round was announced on 12/7/2010.
Transaction Overview
Company Name
Announced On
12/7/2010
Transaction Type
Debt
Venture Equity
Venture Equity
Amount
$20,000,000
Round
Undisclosed
Investors
HLM Venture Partners (Lead Investor) (Edward Cahill)
Clarus (Scott Requadt)
Pappas Ventures (Arthur Pappas)
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
1 Deer Park Drive G
Monmouth Junction, NJ 08852
USA
Monmouth Junction, NJ 08852
USA
Phone
Website
Email Address
Overview
TyRx is dedicated to designing, developing, and commercializing next-generation resorbable polymeric biomaterials. The Company's first series of tyrosine-based resorbable polymer systems have been created for use in drug delivery and medical device applications.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Robert White
Chief Financial Officer
Ray Imp
Chief Medical Officer
Daniel Lerner
VP - Marketing
Randy Mansfield
VP - Product Management
William McJames
VP - Regulatory Affairs
Mark Citron
VP - Regulatory Affairs
Susan Olinger
VP - Sales
Fernando Ochoa
Browse more venture capital transactions:
Prev: 12/7/2010: ESTECH venture capital transaction
Next: 12/7/2010: Zendesk venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are sourced from a variety of public sources. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs